Literature DB >> 2192826

Altered monocyte function in uremia.

R A Gibbons1, O M Martinez, M R Garovoy.   

Abstract

Uremia appears to suppress immune function predisposing patients to infections. When the defect in cellular immunity was studied by exposing mononuclear cells (MNC) from uremic patients and controls to tetanus toxoid, diptheria toxoid, or Candida albicans antigen in vitro, the uremic cells were far less responsive. Monocytes and T cells, which are both involved in the proliferative response to soluble antigens, were isolated from MNC of uremic patients and HLA class II matched controls and incubated with tetanus toxoid. Tetanus toxoid-pulsed uremic monocytes were unable to stimulate the proliferation of HLA identical control T lymphocytes. Lymphocytes from uremic patients, however, were stimulated by tetanus toxoid-pulsed control monocytes. Therefore, the ability of monocytes to function as accessory cells is severely affected by uremia. The uremic monocytes were FcR+, produced IL-1 beta, and expressed levels of HLA class II antigens comparable to controls. Although the biochemical defect in uremic monocytes remains unknown, the abnormality could explain many of the immunological changes of uremia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2192826     DOI: 10.1016/0090-1229(90)90170-u

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  10 in total

1.  Haemodialysis monocytopenia: differential sequestration kinetics of CD14+CD16+ and CD14++ blood monocyte subsets.

Authors:  W A Nockher; J Wiemer; J E Scherberich
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

Review 2.  Update of the mechanism and characteristics of tuberculosis in chronic kidney disease : Review article.

Authors:  Xuehan Zhang; Pingshan Chen; Gaosi Xu
Journal:  Wien Klin Wochenschr       Date:  2022-03-07       Impact factor: 2.275

3.  Candida bloodstream infections in hemodialysis recipients.

Authors:  Vasilios Pyrgos; Kathryn Ratanavanich; Nancy Donegan; Judith Veis; Thomas J Walsh; Shmuel Shoham
Journal:  Med Mycol       Date:  2009       Impact factor: 4.076

4.  Ethambutol and isoniazid induced severe neurotoxicity in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  Meijun Si; Huiqun Li; Yanru Chen; Hui Peng
Journal:  BMJ Case Rep       Date:  2018-05-18

5.  Risk of tuberculosis in dialysis patients: a nationwide cohort study.

Authors:  Claudia C Dobler; Stephen P McDonald; Guy B Marks
Journal:  PLoS One       Date:  2011-12-27       Impact factor: 3.240

6.  Defective antigen presentation by monocytes in ESRD patients not responding to hepatitis B vaccination: impaired HBsAg internalization and expression of ICAM-1 and HLA-DR/Ia molecules.

Authors:  J Stachowski; C Barth; M Pollok; J Michałkiewicz; K Madaliński; J Maciejewski; C A Baldamis
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

7.  Association between renal-limited vasculitis and relapse of antineutrophil cytoplasmic antibody-associated vasculitis: A single-center retrospective cohort study in Japan.

Authors:  Makoto Yamaguchi; Mayumi Ito; Hirokazu Sugiyama; Shiho Iwagaitsu; Hironobu Nobata; Hiroshi Kinashi; Takayuki Katsuno; Masahiko Ando; Yoko Kubo; Shogo Banno; Yasuhiko Ito; Takuji Ishimoto
Journal:  PLoS One       Date:  2022-09-29       Impact factor: 3.752

8.  Decreased antigen-specific T-cell proliferation by moDC among hepatitis B vaccine non-responders on haemodialysis.

Authors:  M A Verkade; C J van Druningen; C T Op de Hoek; W Weimar; M G H Betjes
Journal:  Clin Exp Med       Date:  2007-07-04       Impact factor: 3.984

9.  Chronic kidney disease correlates with increased risk of pulmonary tuberculosis before initiating renal replacement therapy: A cohort study in Taiwan.

Authors:  Kao-Chi Cheng; Kuan-Fu Liao; Cheng-Li Lin; Chiu-Shong Liu; Shih-Wei Lai
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

10.  Effect of chronic kidney disease on all-cause mortality in tuberculosis disease: an Australian cohort study.

Authors:  Beau Z Carr; Esther M Briganti; Joseph Musemburi; Grant A Jenkin; Justin T Denholm
Journal:  BMC Infect Dis       Date:  2022-02-02       Impact factor: 3.090

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.